We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Continues to Deny Approval For Encysive's Thelin
FDA Continues to Deny Approval For Encysive's Thelin
September 7, 2007
The FDA sent a written response to Encysive Pharmaceuticals continuing to deny approval for its pulmonary arterial hypertension drug, Thelin, the company said.